OHSU in the news

Accused: Surrogate endpoints, non-inferiority trials for cancer drugs

MedPage Today April 02, 2019
Vinay Prasad, M.D., M.P.H., and Emerson Chen, M.D., co-author a study raising questions about the length of surrogate measures of effectiveness in cancer clinical trials. Chen says, “Whether this tradeoff of faster but less reliable results is worthwhile for patients deserves further scrutiny.”

Near-infrared dyes specifically light up nerve tissue

Chemical & Engineering News April 02, 2019
Lei Wang, Ph.D., and Summer Gibbs, Ph.D., have created the first near-infrared fluorphores that specifically bind to nerves, which could advance the nerve injury repair.

Hole in one

Woodburn Independent April 02, 2019
OHSU research intern April Vasquez of Woodburn High School is receiving a Chick Evans Scholarship.

Strategies take shape for a new disease state in prostate cancer

OncLive April 01, 2019
Profile highlighting nonmetastatic, castration-resistant prostate cancer, Julie Graff, M.D., describes the spectrum of treating patients with rising PSA levels. She says, “When you don’t have clear data about medical outcomes, quality of life is a perfectly reasonable basis for making decisions.”

Study: C-Section does carry added risks

HealthDay News April 01, 2019
New study finds C-sections carry a higher risk of severe complications than vaginal deliveries, particularly after age 35; Aaron Caughey, M.D., Ph.D., says C-sections inherently create the possibility for complications because "you're making holes in people."

Skipping surgery for rectal cancer

MedPage Today March 29, 2019
In response to a retrospective analysis that reveals most patients with colorectal cancer with complete response to therapeutic agents can skip surgery; Nima Nabavizadeh, M.D., says: “People in the field are excited about it, but we are still waiting for the results of prospective trials to validate the promising retrospective data and give the green light for this to become standard practice.”
See more stories